Betione
Alternative Names: EtioneLatest Information Update: 19 Jun 2020
At a glance
- Originator Progenics Pharmaceuticals
- Class Antianaemics; Antihyperglycaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Aplastic anaemia; Obesity; Type 2 diabetes mellitus
Most Recent Events
- 16 Jun 2020 Progenics Pharmaceuticals has been acquired by Lantheus Holdings
- 21 Jan 2002 Discontinued-II for Aplastic anaemia (Unknown route)
- 21 Jan 2002 Discontinued-II for Obesity (Unknown route)